| node1 | node2 | node1 accession | node2 accession | node1 annotation | node2 annotation | score |
| LRGUK | LRIT1 | ENSPPYP00000020212 | ENSPPYP00000002653 | LRGUK isoform 1. | Leucine rich repeat, Ig-like and transmembrane domains 1. | 0.468 |
| LRGUK | LRIT3 | ENSPPYP00000020212 | ENSPPYP00000016751 | LRGUK isoform 1. | LRIT3 isoform 2. | 0.468 |
| LRGUK | RIPK4 | ENSPPYP00000020212 | ENSPPYP00000012771 | LRGUK isoform 1. | Receptor interacting serine/threonine kinase 4. | 0.570 |
| LRGUK | SVEP1 | ENSPPYP00000020212 | ENSPPYP00000021836 | LRGUK isoform 1. | SVEP1 isoform 1. | 0.604 |
| LRGUK | TONSL | ENSPPYP00000020212 | ENSPPYP00000021282 | LRGUK isoform 1. | TONSL isoform 2. | 0.412 |
| LRIT1 | LRGUK | ENSPPYP00000002653 | ENSPPYP00000020212 | Leucine rich repeat, Ig-like and transmembrane domains 1. | LRGUK isoform 1. | 0.468 |
| LRIT1 | RIPK4 | ENSPPYP00000002653 | ENSPPYP00000012771 | Leucine rich repeat, Ig-like and transmembrane domains 1. | Receptor interacting serine/threonine kinase 4. | 0.556 |
| LRIT1 | SVEP1 | ENSPPYP00000002653 | ENSPPYP00000021836 | Leucine rich repeat, Ig-like and transmembrane domains 1. | SVEP1 isoform 1. | 0.576 |
| LRIT1 | TONSL | ENSPPYP00000002653 | ENSPPYP00000021282 | Leucine rich repeat, Ig-like and transmembrane domains 1. | TONSL isoform 2. | 0.543 |
| LRIT3 | LRGUK | ENSPPYP00000016751 | ENSPPYP00000020212 | LRIT3 isoform 2. | LRGUK isoform 1. | 0.468 |
| LRIT3 | RIPK4 | ENSPPYP00000016751 | ENSPPYP00000012771 | LRIT3 isoform 2. | Receptor interacting serine/threonine kinase 4. | 0.561 |
| LRIT3 | SVEP1 | ENSPPYP00000016751 | ENSPPYP00000021836 | LRIT3 isoform 2. | SVEP1 isoform 1. | 0.576 |
| LRIT3 | TONSL | ENSPPYP00000016751 | ENSPPYP00000021282 | LRIT3 isoform 2. | TONSL isoform 2. | 0.543 |
| MAOA | SELP | ENSPPYP00000022677 | ENSPPYP00000000616 | Amine oxidase [flavin-containing] A; Catalyzes the oxidative deamination of biogenic and xenobiotic amines and has important functions in the metabolism of neuroactive and vasoactive amines in the central nervous system and peripheral tissues. MAOA preferentially oxidizes biogenic amines such as 5-hydroxytryptamine (5-HT), norepinephrine and epinephrine (By similarity). | SELP isoform 2. | 0.627 |
| MAOA | SVEP1 | ENSPPYP00000022677 | ENSPPYP00000021836 | Amine oxidase [flavin-containing] A; Catalyzes the oxidative deamination of biogenic and xenobiotic amines and has important functions in the metabolism of neuroactive and vasoactive amines in the central nervous system and peripheral tissues. MAOA preferentially oxidizes biogenic amines such as 5-hydroxytryptamine (5-HT), norepinephrine and epinephrine (By similarity). | SVEP1 isoform 1. | 0.693 |
| RIPK4 | LRGUK | ENSPPYP00000012771 | ENSPPYP00000020212 | Receptor interacting serine/threonine kinase 4. | LRGUK isoform 1. | 0.570 |
| RIPK4 | LRIT1 | ENSPPYP00000012771 | ENSPPYP00000002653 | Receptor interacting serine/threonine kinase 4. | Leucine rich repeat, Ig-like and transmembrane domains 1. | 0.556 |
| RIPK4 | LRIT3 | ENSPPYP00000012771 | ENSPPYP00000016751 | Receptor interacting serine/threonine kinase 4. | LRIT3 isoform 2. | 0.561 |
| RIPK4 | SVEP1 | ENSPPYP00000012771 | ENSPPYP00000021836 | Receptor interacting serine/threonine kinase 4. | SVEP1 isoform 1. | 0.735 |
| RIPK4 | TONSL | ENSPPYP00000012771 | ENSPPYP00000021282 | Receptor interacting serine/threonine kinase 4. | TONSL isoform 2. | 0.491 |
